Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Data from Intermediate- and Low-Methylation Epigenotypes Do Not Correspond to CpG Island Methylator Phenotype (Low and -Zero) in Colorectal Cancer

View through CrossRef
<div>Abstract<p><b>Background:</b> Most recent genome-wide studies on the CpG island methylation in colorectal cancer (CRC) have led to the discovery of at least 3 distinct methylation clusters. However, there remains an uncertainty whether the CRC clusters identified in these studies represent compatible phenotypes.</p><p><b>Methods:</b> We carried out comprehensive genome-scale DNA methylation profiling by Illumina Infinium HumanMethylation27 of 21 DNA pools that represent 84 CRC samples divided according to their high-, intermediate-, and low-methylation epigenotypes (HME, IME, and LME, respectively) and 70 normal-adjacent colonic tissues. We have also examined the relationship among 3 epigenotypes and chromosomal gains and deletions (assessed by Comparative Genomic Hybridization) in a group of 100 CRC samples.</p><p><b>Results:</b> The HME subgroup showed features associated with CpG island methylator phenotype – high (CIMP-high) including methylation of specific CpG sites (CpGs) as well as significantly lower mean number of chromosomal imbalances when compared with other epigenotypes. The IME subgroup displayed the lowest number of methylated CpGs (717 vs. 2,399 and 2,679 in HME and LME, respectively) and highest mean number of chromosomal imbalances when compared with HME (<i>P</i>, 0.001) and LME (<i>P</i>, 0.004). A comparison between the methylation profiles of 3 epigenotypes revealed more similarities between the HME and LME (1,669 methylated CpGs overlapped) than HME and IME (673 methylated CpGs overlapped).</p><p><b>Conclusion:</b> Our results provide evidence that IME and LME CRCs show opposite features to those that have been previously attributed to CIMP-low and CIMP-0 CRCs.</p><p><b>Impact:</b> These discrepancies should be considered when interpreting the data from a particular epigenotyping method. <i>Cancer Epidemiol Biomarkers Prev; 22(2); 201–8. ©2012 AACR.</i></p></div>
Title: Data from Intermediate- and Low-Methylation Epigenotypes Do Not Correspond to CpG Island Methylator Phenotype (Low and -Zero) in Colorectal Cancer
Description:
<div>Abstract<p><b>Background:</b> Most recent genome-wide studies on the CpG island methylation in colorectal cancer (CRC) have led to the discovery of at least 3 distinct methylation clusters.
However, there remains an uncertainty whether the CRC clusters identified in these studies represent compatible phenotypes.
</p><p><b>Methods:</b> We carried out comprehensive genome-scale DNA methylation profiling by Illumina Infinium HumanMethylation27 of 21 DNA pools that represent 84 CRC samples divided according to their high-, intermediate-, and low-methylation epigenotypes (HME, IME, and LME, respectively) and 70 normal-adjacent colonic tissues.
We have also examined the relationship among 3 epigenotypes and chromosomal gains and deletions (assessed by Comparative Genomic Hybridization) in a group of 100 CRC samples.
</p><p><b>Results:</b> The HME subgroup showed features associated with CpG island methylator phenotype – high (CIMP-high) including methylation of specific CpG sites (CpGs) as well as significantly lower mean number of chromosomal imbalances when compared with other epigenotypes.
The IME subgroup displayed the lowest number of methylated CpGs (717 vs.
2,399 and 2,679 in HME and LME, respectively) and highest mean number of chromosomal imbalances when compared with HME (<i>P</i>, 0.
001) and LME (<i>P</i>, 0.
004).
A comparison between the methylation profiles of 3 epigenotypes revealed more similarities between the HME and LME (1,669 methylated CpGs overlapped) than HME and IME (673 methylated CpGs overlapped).
</p><p><b>Conclusion:</b> Our results provide evidence that IME and LME CRCs show opposite features to those that have been previously attributed to CIMP-low and CIMP-0 CRCs.
</p><p><b>Impact:</b> These discrepancies should be considered when interpreting the data from a particular epigenotyping method.
<i>Cancer Epidemiol Biomarkers Prev; 22(2); 201–8.
©2012 AACR.
</i></p></div>.

Related Results

Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract Background: DNA methylation in promoter regions leads to transcriptional silencing, such as of tumor suppressor genes in cancer. However, the functions of D...
Prediction model construction of mouse stem cell pluripotency using CpG and non-CpG DNA methylation markers
Prediction model construction of mouse stem cell pluripotency using CpG and non-CpG DNA methylation markers
AbstractBackgroundGenome-wide studies of DNA methylation across the epigenetic landscape provide insights into the heterogeneity of pluripotent embryonic stem cells (ESCs). Differe...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
The Prognostic Biomarkers and Immunotherapeutic Targets of Septin in Colon Cancer
The Prognostic Biomarkers and Immunotherapeutic Targets of Septin in Colon Cancer
Abstract BackgroundColon cancer has the third highest incidence and second highest death rate in the world. Colon cancer poses a huge burden to patients and society in Chin...
Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia
Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia
Abstract Abstract 5112 Inactivation of a tumor suppressor gene is often caused by a mutation, small deletion of one allele accompanied by loss of the ...

Back to Top